Chromoblastomycosis is a chronic severely mutilating disease caused by fungi of the order . Classically, has been listed among these etiologic agents. This species is known to occur in the environment and has been found to cause other infections like phaeohyphomycosis, while reported cases of chromoblastomycosis are scant. is phylogenetically diverse, and thus retrospective confirmation of etiology is necessary. We studied ten proven cases of chromoblastomycosis from Mexico and further analyzed the population genetics and genomics of the species to understand their pathogenicity and predilection. The clinical strains were molecularly identified as ( = 4), ( = 4), and ( = 2). No genetic distinction between clinical and environmental strains was possible. Further analysis of strains from diverse origins are needed to address eventual differences in virulence and niche predilection between the species.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910919 | PMC |
| http://dx.doi.org/10.3390/jof7020095 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Deep Fungal Infections of Skin and Role of Histopathology in Diagnosis.
Indian J Dermatol
October 2024
Department of Dermatology, Institute of Child Health, Kolkata, India.
Introduction: Deep mycoses acquired by penetrating trauma to the skin can have varied and sometimes atypical morphological presentations resulting in diagnostic dilemmas and delay in treatment onset. Histopathology can be a useful tool in not only diagnosing but also differentiating various deep mycoses.
Aims And Objectives: To observe various morphological presentations and histopathological features of deep fungal infections.
Chromoblastomycosis in Brazil: A review of 450 published cases.
Rev Soc Bras Med Trop
November 2024
Universidade Federal da Grande Dourados, Faculdade de Ciências da Saúde, Dourados, MS, Brasil.
Chromoblastomycosis is a skin infection caused by melanized fungi that primarily affects rural workers. This study aimed to analyze the clinical and epidemiological manifestations of chromoblastomycosis in Brazil through an extensive literature review. A review of case reports or series of cases in English and Portuguese was conducted using the SciELO, LILACS, SCOPUS, PubMed, and Web of Science databases from 1963 to 2022.
View Article and Find Full Text PDFTriple therapy approach for treating chromoblastomycosis in a Lebanese patient.
Clin Case Rep
October 2024
Department of Dermatology at Saint Georges Hospital University Medical Center, Faculty of Medicine and Medical Sciences Saint George University of Beirut Beirut Lebanon.
Article Synopsis
- Chromoblastomycosis is a rare fungal infection that can appear as chronic skin lesions, especially in non-endemic areas like Lebanon.
- Patients with these persistent, wart-like lesions that don't respond to standard treatments should be evaluated for this condition.
- A combination of oral antifungals, cryotherapy, and topical 5-Fluorouracil has proven effective, with follow-ups showing lasting clearance of lesions and no recurrences at three and six months post-treatment.
Chromoblastomycosis: A Single Centre Clinical Laboratory Experience of Seven Years (2016-2022) and Literature Review From Pakistan.
Mycoses
September 2024
Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
Article Synopsis
- Chromoblastomycosis (CBM) is a chronic skin and tissue infection that has been documented in Pakistan, highlighting varied demographics and treatment outcomes.
- A study analyzed 16 cases of CBM from 2016 to 2022, revealing that most patients were young males, predominantly affected in the lower extremities, and showing specific histopathological features.
- The findings emphasize the need for increased awareness of CBM among healthcare providers in Pakistan, particularly for patients with relevant histories, and call for enhanced collaboration among clinicians and lab specialists for timely diagnosis and treatment.
Chromoblastomycosis in French Guiana: Epidemiology and Practices, 1955-2023.
J Fungi (Basel)
February 2024
Department of Dermatology, Andrée Rosemon Hospital, 97306 Cayenne, French Guiana.
Article Synopsis
- - Chromoblastomycosis (CBM) is a chronic fungal disease primarily found in tropical areas, with limited data on its occurrence in French Guiana from 1950 to 2023, where a study identified 23 mostly male patients, mainly of Creole descent.
- - The majority of cases presented lesions on the lower limbs and had a median diagnosis time of four years, with diagnostic methods including direct microscopy (78.3%) and mycological cultures (69.6%).
- - Treatment approaches varied, involving antifungals like itraconazole and terbinafine, surgery, or a combination of these, with surgery recommended for new, localized lesions, highlighting differences in CBM compared to other mycoses
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!